-
Lixisenatide (trade name
Lyxumia in the
European Union and
Adlyxin in the U.S. and
manufactured by Sanofi) is a once-daily
injectable GLP-1
receptor agonist...
-
manufactured by Eli Lilly),
approved in 2014
lixisenatide (Lyxumia in Europe,
Adlyxin in the
United States,
manufactured by Sanofi),
approved in 2016 semaglutide...
- (Ivermectin), for head lice, now
owned by
Arbor Pharmaceuticals. –
Diabetes Adlyxin (Lixisenatide), for type 2
diabetes mellitus.
Admelog (insulin lispro)...
- Care. 40 (1): 67.
January 2017.
Highlights of
Prescribing Information:
Adlyxin (PDF). FDA. July 2016. pp. 7–8. "Soliqua 100/33". Drugs.com. Christensen...
-
Mission Pharmacal Company, San Antonio, TX, 2007.
Product Information:
ADLYXIN(TM)
subcutaneous injection,
lixisenatide subcutaneous injection. sanofi-aventis...
